Fusion Protein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MTNX-1700 (mTFF2-MSA) suppresses tumor growth and increases survival rates in preclinical colorectal cancer models mTNX-1700 shows single agent activity and additive effects in combination with anti-PD-1 mTNX-1700 targets myeloid-derived suppressor cells (MDSCs) in a novel mechanism to treat cancer CHATHAM, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, today

BOSTON, June 14, 2023 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T... | June 14, 2023

/PRNewswire/ -- The "Global Markets for Bioengineered Protein Drugs" report has been added to ResearchAndMarkets.com's offering. The global bioengineered...

According to a recent Growth Plus Reports study, the global non-opioid pain treatment market is estimated to hit US$ 79.46 billion by 2031, with a revenue

The Business Research Company’s Therapeutic Proteins Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032